Tarpeyo
Ended Awarded Last action
- Contract number
- 36C26024F0271
- Awardee
-
Calliditas Therapeutics US Inc. UEI MAZGQDV5PK59
- Awarding agency
-
Veterans Integrated Service Network 20
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $127,649
Award facts
- Contract value 100% obligated
- $127,649.15 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Cary, NC 27513, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | -$255,298 | |
| Original award | $382,947 |
About this award
This is a federal contract award to Calliditas Therapeutics US Inc., a foreign-owned, for-profit pharmaceutical company, by the U.S. Department of Veterans Affairs (VA). The contract is for the delivery of TARPEYO, a medication used to treat primary immunoglobulin A nephropathy, a serious renal condition, to VA medical facilities nationwide. The contract is a firm fixed-price delivery order under the Pharmaceuticals and Drugs (FSS-61-IB) schedule, with a ceiling value of $127,649.15 and an ultimate completion date of March 11, 2025. Calliditas Therapeutics US Inc. holds two primary federal contract indefinite delivery vehicles (IDVs) with the VA: a Federal Supply Schedule contract and a Blanket Purchase Agreement (BPA), both of which provide a structured mechanism for procuring this specialized pharmaceutical product for veterans with specific renal conditions. The contract does not have a set-aside designation.
Quick answers
Who was awarded contract 36C26024F0271?
36C26024F0271 was awarded to Calliditas Therapeutics US Inc. by Veterans Integrated Service Network 20 (Veterans Health Administration) on March 12, 2024.
How much is contract 36C26024F0271 worth?
The government has obligated $127,649 on 36C26024F0271.
Is contract 36C26024F0271 an order under another contract?
Yes. 36C26024F0271 is a delivery order under 36F79722D0153, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C26024F0271 competed?
The extent of competition for 36C26024F0271 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award